References
- Abe C, Mitsunaga K, Shiokawa Y. (1980). Spontaneous polyarthritis in MRL/l mice. Ryumachi. 20:233–9
- Arnett FC, Edworthy SM, Bloch DA, et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–24
- Arvidson NG, Gudbjörnsson B, Elfman L, et al. (1994). Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 53:521–4
- Baumann H, Gauldie J. (1994). The acute phase response. Immunol Today. 15:74–80
- Bellamy N, Sothern RB, Campbell J, Buchanan WW. (1991). Circadian rhythm in pain, stiffness and manual dexterity in rheumatoid arthritis: Relation between discomfort and disability. Ann Rheum Dis. 50:243–8
- Bellamy N, Sothern RB, Campbell J, Buchanan WW. (2002). Rhythmic variations in pain, stiffness and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 61:1075–80
- Chu CQ, Field M, Feldmann M, Maini RN. (1991). Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125–32
- Crofford LJ, Kalogeras KT, Mastorakos G, et al. (1997). Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 82:1279–83
- Cutolo M, Seriolo B, Craviotto C, et al. (2003). Circadian rhythms in RA. Ann Rheum Dis. 62:593–6
- Danning CL, Illei GG, Hitchon C, et al. (2000). Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 43:1244–56
- Ding Y, Qin L, Zamarin D, et al. (2001). Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol. 167:6884–92
- Edwards CK 3rd, Zhou T, Zhang J, et al. (1996). Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. J Immunol. 157:1758–72
- Feldmann M, Brennan FM, Maini RN. (1996). Role of cytokines in rheumatoid arthritis. Ann Rev Immunol. 14:397–440
- Firestein GS. (2004). NF-kappaB: Holy Grail for rheumatoid arthritis? Arthritis Rheum. 50:2381–6
- Gabay C. (2002). Cytokine inhibitors in the treatment of rheumatoid arthritis. Expert Opin Biol Ther. 2:135–49
- Gabay C, Kushner I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340:448–54
- Gabriel SE. (2001). The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 27:269–81
- Hang L, Theofilopoulos AN, Dixon FJ. (1982). A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med. 155:1690–701
- Harris ED Jr. (1990). Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med. 322:1277–89
- Herold M, Günther R. (1987). Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis. Prog Clin Biol Res. 227B:271–9
- Kacskovics I, Kis Z, Mayer B, et al. (2006). FcRn mediates elongated serum half-life of human IgG in cattle. Int Immunol. 18:525–36
- Kanasaki Y, Tomonari M, Sasaki H, To H. (2012). Chronopharmacology of mizoribine in collagen-induced arthritis rats. J Pharmacol Sci. 120:112–20
- Kim J, Bronson CL, Wani MA, et al. (2008). Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn-alpha-chain deficient mice. Exp Biol Med (Maywood). 233:603–9
- Kluve-Beckerman B, Yamada T, Hardwick J, et al. (1997). Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2. Biochem J. 322:663–9
- Koopman WJ, Gay S. (1988). The MRL-lpr/lpr mouse: A model for the study of rheumatoid arthritis. Scand J Rheumatol. 75:284–9
- Kowanko IC, Knapp MS, Pownall R, Swannell AJ. (1982). Domiciliary self-measurement in the rheumatoid arthritis and the demonstration of circadian rhythmicity. Ann Rheum Dis. 41:453–5
- Kuramoto Y, Hata K, Koyanagi S, et al. (2006). Circadian regulation of mouse topoisomerase I gene expression by glucocorticoid hormones. Biochem Pharmacol. 71:1155–61
- Li Q, Verma IM. (2002). NF-kappaB regulation in the immune system. Nat Rev Immunol. 2:725–34
- McInnes IB, Liew FY. (2005). Cytokine networks: Towards new therapies for rheumatoid arthritis. Nat Clin Prac Rheumatol. 1:31–9
- Marotte H, Ahmed S, Ruth JH, Koch AE. (2010). Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A. Arthritis Rheum. 62:722–31
- Mebius RE, Kraal G. (2005). Structure and function of the spleen. Nat Rev Immunol. 5:606–16
- Mullan RH, Bresnihan B, Golden-Mason L, et al. (2006). Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum. 54:105–14
- Obayashi K, Tomonari M, Yoshimatsu H, et al. (2011). Dosing-time dependency of the arthritis inhibiting effect of tacrolimus in collagen-induced arthritis mice. J Pharmacol Sci. 116:264–73
- Olsen NJ, Stein CM. (2004). New drugs for rheumatoid arthritis. N Engl J Med. 350:2167–79
- O'Rourke KP, O'Donoghue G, Adams C, et al. (2008). High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: Clinical and cytokine correlations. Rheumatol Int. 28:979–86
- Palmer G, Chobaz V, Talabot-Ayer D, et al. (2004). Assessment of the efficacy of different statins in murine collagen-induced arthritis. Arthritis Rheum. 50:4051–9
- Perry MG, Kirwan JR, Jessop DS, Hunt LP. (2009). Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis. 68:63–8
- Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int 27:1911–29
- Rajasingh J, Bord E, Luedemann C, et al. (2006). IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 20:2112–14
- Schlüter D, Deckert M. (2000). The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect. 2:1285–92
- Tarkowski A, Czerkinsky C, Nilsson LA. (1984). Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: A kinetic study. Clin Exp Immunol. 58:7–12
- Theofilopoulos AN, Dixon FJ. (1985). Murine models of systemic lupus erythematosus. Adv Immunol. 37:269–390
- To H, Irie S, Tomonari M, et al. (2009). Therapeutic index of methotrexate depends on circadian cycling of tumor necrosis factor-α in collagen-induced arthritis rats and mice. J Pharm Pharmacol. 61:1333–8
- To H, Yoshimatsu H, Tomonari M, et al. (2011). Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int. 28:267–74
- Zenz R, Eferl R, Scheinecker C, et al. (2008). Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 10:201. doi: 10.1186/ar2338